4
Changes in Ownership
Lexaria Bioscience Corp. Filed Acc 0001103780-16-000076
CEO bought 20,000 shares at an average $0.17 ($3,325)
From the SEC's structured data for this filing
Trades in this filing
BUNKA CHRISTOPHER · CEO
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2016-01-04 | Purchase : show line 1 in the form | +5,000 | $0.16 | $775 | 4,942,854 | I |
| 2016-01-04 | Purchase : show line 2 in the form | +10,000 | $0.17 | $1,650 | 4,952,854 | I |
| 2016-01-04 | Purchase : show line 3 in the form | +5,000 | $0.18 | $900 | 4,957,854 | I |
| Open-market purchases · 20,000 sh · avg $0.17 · $3,325 | ||||||
Loading xslF345X03/primary_doc.xml…